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Background. A slow (<60 bpm), steady heart rate is necessary for optimal imaging during coronary computed tomographic angiography (CCTA) 
using current generation scanners. Oral/intravenous beta-blockers are often used but target heart rates are not achieved in 15-20% of patients 
despite maximally tolerated doses. We aimed to investigate the influence of Arg389Gly and Ser49Gly single nucleotide polymorphisms (SNP) of the 
`1-adrenergic receptor (B1AR) on heart rate response to metoprolol in patients referred for CCTA. 
Methods. BAR genotyping at codons 389 and 49 was performed using polymerase chain reaction with restriction fragment length polymorphism 
analysis in 200 adults (age 56±11 years, 53% men) undergoing CCTA using a 64-slice scanner. 
Results. Overall, 37 (18.5%) did not reach target heart rate (<60 bpm). Mean oral/intravenous metoprolol doses were 181±116 and 4.2±9.4 mg, 
respectively. Codon 49: higher percentage of patients who carried the Gly allele (n=49) failed to reach target heart rate compared to those with Ser-
Ser genotype (n=151) (29%-vs-15%, p=0.04) despite higher administered doses of both oral (210±115 vs 172±115 mg, p<0.05) and intravenous 
(7±13 vs 3±8 mg, p=0.06) metoprolol in the former. Codon 389: Similarly, a higher percentage of patients with Gly-Gly genotype (n=11) failed to 
reach target heart rate compared to those who carried the Arg allele (n=189) [45%-vs-17%, p=0.02) despite higher doses of intravenous metoprolol 
(13±15 vs 4±8 mg, p=0.002). Oral metoprolol dose was not significantly different between latter 2 groups (162±105 vs 182±117 mg, p=NS). 
Conclusion. This data suggests that the selected functional polymorphisms of B1AR substantially influence the magnitude of heart rate response 
to acute beta-blockade in patients referred for CCTA.
